fbpx
John Hudak returns to give us a comprehensive breakdown of what to expect from Election Day 2016. This episode goes up 5 days prior to Nov. 8th so we discuss House, Senate and Gubernatorial races as well as the  outlook in North Carolina, Montana, Missouri, Ohio, Illinois, Colorado, Nevada, Pennsylvania and Arizona specifically to name a few. We don’t discuss John’s book “Marijuana, A Short History” available at Brookings, Amazon and Barnes & Noble now, but stay tuned, we will next time. But for this time, we begin with a piece of John’s first interview in episode 163 this summer on de vs. rescheduling to showcase his power of prognostication…and intellect.

Transcript:

Speaker 1: John Hudak returns John Hudak returns to give us a comprehensive breakdown of what to expect from Election Day 2016. This episode goes up five days prior to Nova Braids, so we discussed how senate and gubernatorial races as well as the outlook in North Carolina, Montana, Missouri, Ohio, Illinois, Colorado, Nevada, Pennsylvania, and Arizona. Specifically. To name of you, welcome to cannabis economy. I'm your host Seth Adler. Check us out on social with the handle can economy. That's two ends and the word economy. We don't discuss John's book, marijuana, a short history available at brookings, Amazon, and Barnes and noble now, but stay tuned. We will next time, but for this time we begin with a piece of John's first interview in episode one 63 this summer on d versus rescheduling to showcase his power of prognostication and intellect of the Brookings Institution. John Hudak. Let's just tackle.

Speaker 2: I'm rescheduling or what I like to, uh, what I prefer. Dea Scheduling. There's noise here about rescheduling and all of that noise seems to sound like scheduled to. We don't need to re litigate a, you know, the difference between going to schedule two and schedule five or dea scheduling. But what do you see? What do you hear? What do you think? Sure. So FDA has made, there's a current rescheduling petition before the federal government that was filed by Lincoln, chafee, the then governor of Rhode Island, and Christine Gregoire, the then governor of Washington. Um, it has been a under evaluation for five years. Um, they, uh, FDA has a, it has been announced, has made the recommendation to dea. Dea has said they will make their decision sometime this summer. It will come through dea and the Department of Justice. I will be shocked if marijuana is rescheduled. I think that historically and statutorily it is unlikely that dea is going to move in that direction.

Speaker 2: I think they should, I think they should reschedule for a variety of reasons, but, uh, I think it's hard to imagine d e a reversing themselves on this point, especially because I think they look at the system as it is and they say that's good enough. Dea is not a productive institution. It's a law enforcement entity that has spent its entire existence. I'm prosecuting the war on drugs and this is a signal that there is a weakness there. The new DEA chief I think has shown himself not to be a friend of the marijuana reform community and while there are legitimate research reasons why rescheduling is probably a good idea and I think there are a lot of myths about what rescheduling will do. That, those are myths both among marijuana opponents and also among the marijuana industry actors. There are different myths, but myths, all the same.

Read the full transcript:

Become a member to access to webinars, quarterly reports, contributor columns, shows, excerpts, and complete podcast transcripts

Become a Member

Already a member? Login here.